Local tumor irradiation augments the antitumor effect of cytokine-producing autologous cancer cell vaccines in a murine glioma model

Cancer Gene Therapy

Volumn 9, Issue 1, 2002, Pages 44-52

  Lumniczky, Katalin ^a   Desaknai, Szilvia ^a   Mangel, Laszlo ^b   Szende, Bela ^c   Hamada, Hirofumi ^d   Hidvegi, Egon J ^a   Safrany, Geza ^a  

^a National Research Institute for Radiobiology and Radiohygiene Budapest   (Hungary)

^b NATIONAL INSTITUTE OF ONCOLOGY   (Hungary)

^c SEMMELWEIS UNIVERSITY   (Hungary)

^d SAPPORO MEDICAL UNIVERSITY   (Japan)

Author keywords

Antiglioma vaccine; GM CSF; IL 12; IL 4; Irradiation

Indexed keywords

CANCER VACCINE; CD4 ANTIGEN; CD8 ANTIGEN; CYTOKINE; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; INTERLEUKIN 12; INTERLEUKIN 4; INTERLEUKIN 6; INTERLEUKIN 7; LEUKEMIA INHIBITORY FACTOR; LEUKOTRIENE; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTINEOPLASTIC ACTIVITY; ARTICLE; BRAIN TUMOR; CANCER RADIOTHERAPY; CONTROLLED STUDY; CYTOKINE RELEASE; CYTOTOXIC T LYMPHOCYTE; DRUG CYTOTOXICITY; DRUG POTENTIATION; GENE THERAPY; GENETIC TRANSDUCTION; GLIOMA; IN VITRO STUDY; LYMPHOCYTE ACTIVATION; LYMPHOCYTIC INFILTRATION; MOUSE; NONHUMAN; PRIORITY JOURNAL; T LYMPHOCYTE SUBPOPULATION; TREATMENT OUTCOME; VACCINATION;

ADENOVIRIDAE; ANIMALS; BRAIN NEOPLASMS; CANCER VACCINES; CD4-POSITIVE T-LYMPHOCYTES; CD8-POSITIVE T-LYMPHOCYTES; COMBINED MODALITY THERAPY; CYTOTOXICITY, IMMUNOLOGIC; GENETIC VECTORS; GLIOMA; GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR; INTERLEUKIN-4; LYMPHOCYTE ACTIVATION; MICE; MICE, INBRED C57BL; TRANSFECTION; TUMOR NECROSIS FACTOR-ALPHA; VACCINATION;

ANIMALIA; MURINAE;

EID: 85047696411     PISSN: 09291903     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.cgt.7700398     Document Type: Article

References (40)

1. National survey of patterns of care for brain-tumor patients
2. Gene therapy approaches to enhance antitumor immunity
3. Vaccination with irradiated tumor cells engineered to secrete murine granulocyte-macrophage colony-stimulating factor stimulates potent, specific, and long-lasting anti-tumor immunity
4. Immunizing and curative potential of replicating and nonreplicating murine mammary adenocarcinoma cells engineered with interleukin (IL)-2, IL-4, IL-6, IL-7, IL-10, tumor necrosis factor alpha, granulocyte-macrophage colony-stimulating factor, and gamma-interferon gene or admixed with conventional adjuvants
5. Treatment of intracranial tumors by systemic transfer of superantigen-activated tumor-draining lymph node T cells
6. Brain tumor treatment with IL-2 and IL-12 producing autologous cancer cell vaccines
7. Studies on the chemotherapy of experimental brain tumors: Evaluation of 1, 3-bis(2chloroethyl)-1-nitrosourea, cyclophosphamide, mithramycin and methotrexate
8. Adoptive immunotherapy with murine tumor-specific T lymphocytes engineered to secrete interleukin 2
9. Definition of a unique cell surface antigen of mouse leukemia RL1 by cell-mediated cytotoxicity
10. Immunotherapy of bladder cancer with cytokine gene-modified tumor vaccines
11. Glioma immunology and immunotherapy
12. Intensified antitumor immunity by a cancer vaccine that produces granulocyte-macrophage colony-stimulating factor plus interleukin 4
13. + cell-mediated immunity against tumors located in the immunologically privileged central nervous system
14. Gene therapy for metastatic brain tumors by vaccination with granulocyte-macrophage colony-stimulating factor-transduced tumor cells
15. Eradication of rat malignant gliomas by retroviral-mediated, in vivo delivery of the interleukin 4 gene
16. + T cells by interleukin-4-transfected 9L gliosarcoma is essential for protective immunity
17. Evaluation of combined vaccinia virus-mediated antitumor gene therapy with p53, IL-2, and IL-12 in a glioma model
18. Low-dose vaccinia virus-mediated cytokine gene therapy of gliomas
19. The treatment of established intracranial tumors by in situ retroviral IFN-gamma transfer
20. Immunological responsiveness to interleukin-2-producing brain tumors can be restored by concurrent subcutaneous transplantation of the same tumors
21. Paracrine delivery of IL-12 against intracranial 9L gliosarcoma in rats
22. Effective cytokine gene therapy against an intracranial glioma using a retrovirally transduced IL-4 plus HSVtk tumor vaccine
23. Effect of in situ retroviral interleukin-4 transfer on established intracranial tumors
24. Expression of murine interleukin 7 in a murine glioma cell line results in reduced tumorigenicity in vivo
25. Vaccination for experimental gliomas using GM-CSF-transduced glioma cells
26. IFN-beta gene therapy induces systemic antitumor immunity against malignant glioma
27. Helper virus-free herpes simplex virus type 1 amplicon vectors for granulocyte-macrophage colony-stimulating factor-enhanced vaccination therapy for experimental glioma
28. Prolongation of survival of mice with glioma treated with semiallogeneic fibroblasts secreting interleukin-2
29. Antitumor effect and cellular immunity activation by murine interferon-beta gene transfer against intracerebral glioma in mouse
30. Adenovirus mediated gene therapy in a glioblastoma vaccine model; specific antitumor immunity and abrogation of immunosuppression
31. Combined effects of radiotherapy and angiostatin gene therapy in glioma tumor model
32. Evaluation of radiation effects against C6 glioma in combination with vaccinia virus-p53 gene therapy
33. Enhanced radio-sensitivity of malignant glioma cells after adenoviral p53 transduction
34. Combined radiation and p53 gene therapy of malignant glioma cells
35. Evaluation of pGL1-TNF-alpha therapy in combination with radiation
36. Adenoviral TNF-alpha gene therapy and radiation damage tumor vasculature in a human malignant glioma xenograft